Financials
- Market Capitalization 186.49 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3666 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.33 USD | +0.87% | -2.92% | +15.35% | -20.21% | 187.73 M USD | ||
| 3670 | QSI Quantum-Si Incorporated - Class A Common Stock | 0.86 USD | -1.15% | -5.49% | -11.34% | -52.49% | 187.27 M USD | ||
| 3675 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 11.61 USD | +4.97% | -7.56% | -0.34% | -22.65% | 185.07 M USD | ||
| 3685 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.84 USD | -2.33% | -4.55% | +20.00% | +15.07% | 182.28 M USD |
Frequently asked questions about ProQR Therapeutics N.V. - Ordinary Shares
What is the ProQR Therapeutics N.V. - Ordinary Shares stock price today?
The current price of ProQR Therapeutics N.V. - Ordinary Shares (PRQR) is 1.77. Over the past 24 hours, the stock has changed by +4.12%. Follow the PRQR chart for real-time price dynamics.
What is the stock ticker of ProQR Therapeutics N.V. - Ordinary Shares?
ProQR Therapeutics N.V. - Ordinary Shares trades under the ticker PRQR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ProQR Therapeutics N.V. - Ordinary Shares stock going up?
PRQR has changed by +3.51% over the last week, +17.22% over the last month, and -24.68% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does ProQR Therapeutics N.V. - Ordinary Shares have?
As of the latest available data, ProQR Therapeutics N.V. - Ordinary Shares has 187 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy ProQR Therapeutics N.V. - Ordinary Shares stock?
You can buy ProQR Therapeutics N.V. - Ordinary Shares (PRQR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ProQR Therapeutics N.V. - Ordinary Shares stock?
Investing in ProQR Therapeutics N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRQR chart and related analysis on metatrader.com as part of your research.